Japan Single Cell Sequencing Market (2025-2030)
The Japan Single Cell Sequencing Market was valued at $72 Million in 2025 and projected to reach to $130.1 Million by 2030, representing a compound annual growth rate of 12.6%. Japan's single cell sequencing market is poised for sustained expansion, driven by increasing investments in precision medicine and genomic research infrastructure.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
Japan Single Cell Sequencing Market Trends and Insights
- Japan is establishing itself as a key player in Asia Pacific's genomics landscape, driven by advanced research infrastructure and significant investment in precision medicine initiatives.
- The market in Japan reflects strong adoption across academic institutions, pharmaceutical companies, and clinical research centers seeking to unlock cellular-level insights for drug discovery and disease understanding. The 12.6% compound annual growth rate in Japan outpaces global trends, underscoring the country's commitment to biotechnology innovation and genomic research.
- Japan's aging population and focus on personalized healthcare solutions are accelerating demand for single cell sequencing technologies.
- Between 2025 and 2030, Japan is expected to consolidate its position as a regional innovation hub, with expanding applications in oncology, immunology, and regenerative medicine driving market expansion..
Key Market Statistics
- CAGR (2025-2030) 12.6% CAGR
- Market Size, 2025 ~USD 72 Million
- Forecast, 2030 ~USD 130.1 Million
- Country Japan
Japan Single Cell Sequencing Market Overview
Market Valuation Growth :
Japan's single cell sequencing market is valued at $72.0 million in 2025, with a projected CAGR of 12.6% through 2030, reaching $130.1 million. This growth trajectory outpaces the global average of 12.2%, positioning Japan as a high-growth market in the Asia Pacific region.
Advanced Research Infrastructure :
Japan possesses world-class research facilities and genomics centers that drive adoption of single cell sequencing technologies. Leading academic institutions and research organizations are investing heavily in precision medicine and cellular analysis capabilities.
Precision Medicine Investment :
Japanese government and private sector initiatives in precision medicine are accelerating single cell sequencing adoption. Strategic funding and regulatory support for genomic research are creating favorable conditions for market expansion across pharmaceutical and biotech sectors.
Academic Sector Leadership :
Japan's strong academic research community is a primary driver of single cell sequencing adoption. Universities and research institutes are implementing advanced sequencing platforms for cancer research, immunology, and developmental biology applications.
Japan Single Cell Sequencing Market Dynamics
- The country's commitment to advancing cellular-level analysis technologies positions it as a critical hub for single cell sequencing innovation in Asia Pacific.
- Academic institutions and pharmaceutical companies are rapidly adopting these technologies to accelerate drug discovery and personalized treatment development. The forecast period through 2030 will see growing integration of single cell sequencing into clinical diagnostics and therapeutic development pipelines.
- Japan's aging population and focus on age-related disease research will further propel market growth.
- Collaborations between government research agencies, universities, and biotech companies will strengthen Japan's competitive position in the global single cell sequencing landscape..
Related Ecosystem
Advanced Genetic Sequencing
- Polymerase Chain Reaction (PCR)
- Reagents
- Assay Kits
- Bioinformatics
- Flow Cytometry
- Thermo Fisher Scientific Inc.
- Illumina, Inc.
- Agilent Technologies, Inc.
- Qiagen N.V.
- Danaher Corporation
Biotechnology
- Reagents
- Polymerase Chain Reaction (PCR)
- Stem Cells
- Assay Kits
- Flow Cytometers
- Thermo Fisher Scientific Inc.
- Merck KGaA
- Danaher Corporation
- Agilent Technologies, Inc.
- Bio-Rad Laboratories, Inc.
Key Takeaways
- Japan's single cell sequencing market is valued at $72.0 million in 2025 and is forecast to reach $130.1 million by 2030, representing a 12.6% CAGR.
- Japan's growth rate exceeds the global average, reflecting strong institutional investment and government support for genomic research infrastructure.
- Japan's aging demographic and emphasis on precision medicine are key drivers accelerating single cell sequencing adoption across research and clinical settings.
- Japan is positioned as a regional leader in Asia Pacific, with expanding applications in oncology, immunology, and regenerative medicine through 2030.
Single Cell Sequencing Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2025 |
| Fastest Growing Segment | SERVICES (Offering) |
| Forecast Period | 2025–2030 |
| Growth Rate | CAGR of 12.2% from 2025 to 2030 |
| Largest Segment | PRODUCTS (Offering) |
| Market Size Base Year (Billions) | ~USD 1.95 (2025) |
| Revenue Forecast (Billions) | ~USD 3.46 (2030) |
| Segments Covered | Offering, Type, End User, Sequencing Type, Application, Workflow |
Japan Single Cell Sequencing Market Report Segmentation
6 segment dimensions are covered across the global market.
By Offering
- Products
- Services
By Type
- Basic & Translational Research
- Cancer Research
- Cell Sorters
- Consumables
- Data Analysis & Bioinformatics Services
- Data Storage & Management Software
- Drug Discovery & Development
- Instruments
- Lcm Instruments
- Library Preparation Services
- Microbiology & Infectious Diseases
- Microfluidic Instruments
- Neurology & Brain Research
- Organ Development & Regenerative Medicine
- Other Pre-Sequencing Instruments
- Pcr Instruments
- Pre-Sequencing Instruments
- Pre-Sequencing Reagents & Kits
- Pre-Sequencing Services
- Sample Preparation, Single-Cell Isolation, And Enrichment Services
- Sequencing Platforms
- Sequencing Reagents & Kits
- Sequencing Services
- Software
- Software Tools
- Stem Cell & Developmental Biology
By End User
- Academic & Research Institutes
- Biotechnology & Pharmaceutical Companies
- Cros
- Hospitals & Clinical Laboratories
- Pharmaceutical & Biopharmaceutical Companies
By Sequencing Type
- Other Single-Cell Sequencing Types
- Scatac-Seq
- Scdna-Seq
- Scrna-Seq
By Application
- Diagnostic & Clinical Applications
- Research Applications
By Workflow
- Data Analysis & Interpretation
- Pre-Sequencing
- Sequencing
JAPAN: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY END USER, 2023–2030
| Segment | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | CAGR (%) |
|---|---|---|---|---|---|---|---|---|---|
| ACADEMIC & RESEARCH INSTITUTES | 29.03 | 29.53 | 30.43 | 32.62 | 36.06 | 40.88 | 47.26 | 55.54 | 12.8 |
| CROS | 7.46 | 7.5 | 7.63 | 8.08 | 8.82 | 9.87 | 11.27 | 13.08 | 11.4 |
| HOSPITALS & CLINICAL LABORATORIES | 13.03 | 13.15 | 13.44 | 14.28 | 15.66 | 17.61 | 20.18 | 23.52 | 11.8 |
| PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES | 19.4 | 19.81 | 20.47 | 22.02 | 24.43 | 27.79 | 32.23 | 38 | 13.2 |
| TOTAL | 68.9 | 70 | 72 | 77 | 85 | 96.1 | 110.9 | 130.1 | 12.6 |
JAPAN: SINGLE-CELL SEQUENCING SERVICES MARKET, BY END USER, 2023–2030
| Segment | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | CAGR (%) |
|---|---|---|---|---|---|---|---|---|---|
| ACADEMIC & RESEARCH INSTITUTES | 8.67 | 9.92 | 10.8 | 12.13 | 13.87 | 16.2 | 19.38 | 23.71 | 17 |
| BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES | 7.04 | 8.11 | 8.89 | 10.05 | 11.56 | 13.59 | 16.37 | 20.15 | 17.8 |
| HOSPITALS & CLINICAL LABORATORIES | 4.4 | 4.94 | 5.28 | 5.82 | 6.54 | 7.49 | 8.79 | 10.54 | 14.8 |
| TOTAL | 20.11 | 22.97 | 24.97 | 28 | 31.97 | 37.28 | 44.55 | 54.41 | 16.9 |
Target Audience
- Pharmaceutical & Biotech Companies : Japanese and international pharma/biotech firms need market intelligence to guide R&D investments, clinical trial strategies, and precision medicine initiatives. Understanding Japan's single cell sequencing adoption helps optimize drug development pipelines and personalized medicine programs.
- Sequencing Technology Providers : Equipment manufacturers and software vendors require detailed market data to identify sales opportunities, assess competitive positioning, and develop Japan-specific product strategies. Market insights inform pricing, distribution, and customer acquisition approaches.
- Academic & Research Institutions : Japanese universities and research centers need market analysis to benchmark their genomics capabilities, identify funding opportunities, and plan technology investments. Understanding market trends supports grant applications and research collaboration strategies.
- Healthcare & Diagnostic Companies : Clinical diagnostic providers and hospital networks require insights into single cell sequencing adoption in Japan's healthcare system. Market data supports decisions on integrating advanced sequencing into diagnostic portfolios and precision medicine services.
- Investment & Venture Capital Firms : Investors targeting Japan's biotech and genomics sectors need comprehensive market analysis to evaluate investment opportunities and portfolio companies. Market forecasts and growth drivers inform funding decisions and exit strategies in the Japanese market.
Reasons to Buy this Report
- Market Size & Growth Validation : Obtain precise market valuation data for Japan's single cell sequencing sector with verified CAGR of 12.6% through 2030. Validate investment decisions and business expansion strategies with comprehensive market sizing and forecasting specific to the Japanese market.
- Competitive Landscape Intelligence : Understand Japan's unique market dynamics, key players, and competitive positioning within Asia Pacific. Identify opportunities for market entry, partnerships, and differentiation in Japan's growing precision medicine ecosystem.
- Academic & Research Sector Insights : Access detailed analysis of Japan's academic research adoption patterns and institutional spending on single cell sequencing technologies. Identify key research centers and funding opportunities driving market growth in the university and research institute segments.
- Regulatory & Investment Environment : Gain clarity on Japan's regulatory framework, government funding initiatives, and precision medicine policies supporting single cell sequencing adoption. Understand the investment landscape and strategic priorities shaping market development through 2030.
- Strategic Market Planning : Develop targeted go-to-market strategies for Japan with data-driven insights on customer segments, adoption drivers, and growth catalysts. Make informed decisions on product localization, pricing, and partnership strategies specific to the Japanese market.
Frequently asked questions
What is the current market size of single cell sequencing in Japan?
Japan's single cell sequencing market is valued at $72.0 million in 2025, with strong growth anticipated through the forecast period.
What is the projected market size for single cell sequencing in Japan by 2030?
Japan's single cell sequencing market is projected to reach $130.1 million by 2030, representing significant expansion from 2025 levels.
What is the CAGR for Japan's single cell sequencing market?
Japan's single cell sequencing market is growing at a compound annual growth rate of 12.6% between 2025 and 2030.
What factors are driving growth in Japan's single cell sequencing market?
Key drivers in Japan include advanced research infrastructure, government support for genomic innovation, an aging population, and increased adoption of precision medicine approaches.
Which applications are leading demand for single cell sequencing in Japan?
Oncology, immunology, and regenerative medicine are among the primary applications driving single cell sequencing adoption across Japan's research and clinical institutions.
RESEARCH METHODOLOGY
This research study extensively used secondary sources, directories, and databases to identify and collect valuable information to analyze the global single-cell sequencing market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information and assess the market's growth prospects. The global market size estimated through secondary research was then triangulated with inputs from primary research to arrive at the final market size.
Secondary Research
Secondary research was used mainly to identify and collect information for the extensive, technical, market-oriented, and commercial study of the single cell sequencing market. The secondary sources used for this study The secondary sources used for this study include the World Health Organization (WHO), the Centers for Disease Control and Prevention (CDC), the International Clinical Cytometry Society (ICCS), the International Society for Advancement of Cytometry (ISAC), the National Institutes of Health (NIH), the Organisation for Economic Co-operation and Development (OECD), and the Society for Laboratory Automation and Screening (SLAS); Corporate and Regulatory Filings, Annual Reports, Sec Filings, Investor Presentations, and Financial Statements; Business Magazines & Research Journals; Press Releases, MarketsandMarkets Analysis. These sources also obtained key information about major players, market classification, and segmentation according to industry trends, regional/country-level markets, market developments, and technology perspectives.
Primary Research
Extensive primary research was conducted after acquiring basic knowledge about the global single-cell sequencing market scenario through secondary research. Several primary interviews were conducted with market experts from both the demand side (personnel from, pharmaceutical & and biotechnology companies, hospitals & diagnostic laboratories, academic & research institutes, and contract research organization) and supply side (C-level and D-level executives, product managers, and marketing and sales managers of key manufacturers, distributors, and channel partners, among others, across six major regions—North America, Europe, the Asia Pacific, Latin America, Middle East, and Africa. Approximately 70% of primary interviews were conducted with supply-side representatives, while demand-side participants accounted for the remaining share. This preliminary data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews.
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate and validate the total size of the single-cell sequencing market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
Single Cell Sequencing Market : Top-Down and Bottom-Up Approach
Data Triangulation
After arriving at the overall market size from the market size estimation process explained above, the total market was divided into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable.
Market Definition
Single-cell sequencing (SCS) is a genomic technology that allows researchers to study the genetic material of individual cells. Unlike traditional sequencing methods that analyze bulk cell populations, single-cell sequencing helps identify differences between individual cells, providing a clearer understanding of cell functions, disease mechanisms, and treatment responses. The scope of the single-cell sequencing market includes a wide range of products and services used across the entire single-cell workflow. This covers pre-sequencing instruments and consumables (such as cell isolation tools and library preparation kits), sequencing instruments and consumables, and software for analyzing single-cell data. The market also includes services provided by third parties across pre-sequencing, sequencing, and data analysis stages. The market also studies various sequencing types, including single-cell RNA sequencing (scRNA-seq), single-cell DNA sequencing (scDNA-seq), and single-cell ATAC sequencing (scATAC-seq), among others. These technologies are widely used in basic and translational research, drug discovery, and clinical applications, especially in cancer, neurological, and infectious diseases. End users of these solutions studied in the report include academic and research institutions, pharmaceutical and biotechnology companies, hospitals and diagnostic labs, and contract research organizations (CROs).
Stakeholders
- Academic & Research Institutes
- Single-cell Sequencing Assay & Reagent Manufacturers, Vendors, and Distributors
- Contract Research Organizations (CROs)
- Single-cell Sequencing Service & Software Providers
- Diagnostics Companies
- Market Research & Consulting Firms
- Pharmaceutical & Biotechnology Companies
- Regulatory Agencies
- Venture Capitalists
- Government organizations
- Contract Development & Manufacturing Organizations (CDMOs)
- Hospitals and Diagnostic Laboratories
Report Objectives
- To define, describe, and forecast the global single-cell sequencing market based on offering, product type, product workflow, product end user, service type, service end user, sequencing type, application, and region
- To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
- To strategically analyze micro-markets with respect to individual growth trends, prospects, and contributions to the overall market
- To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
- To forecast the size of the market segments with respect to six central regions, namely, North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa
- To profile the key players in the global single-cell sequencing market and comprehensively analyze their core competencies and market shares
- To track and analyze competitive developments such as acquisitions, product launches & approvals, expansions, agreements, partnerships, and collaborations in the single-cell sequencing market
- To benchmark players in the single-cell sequencing market using the “Company Evaluation Matrix” framework, which analyzes market players based on various parameters, including product portfolio, geographic reach, and market share
Available Customizations
With the given market data, MarketsandMarkets offers customizations to meet the company’s needs. The following customization options are available for the report:
Geographical Analysis
- Further breakdown of the Rest of Europe’s single-cell sequencing market, by country
- Further breakdown of the Rest of Asia Pacific’s single-cell sequencing market, by country
- Further breakdown of the Rest of Latin America’s single-cell sequencing market, by country
- Further breakdown of the Rest of the Middle East’s single-cell sequencing market, by country
Company Information
- Detailed analysis and profiling of additional market players (up to five)
Segment Analysis
- Further breakdown of the other technologies into subsegments
- Cross-segment analysis
Get the Full Single Cell Sequencing Market Report
Full forecast, segment splits, and company analysis for all Single Cell Sequencing Market.
- US Single Cell Sequencing Market
- Canada Single Cell Sequencing Market
- UK Single Cell Sequencing Market
- Germany Single Cell Sequencing Market
- France Single Cell Sequencing Market
- Italy Single Cell Sequencing Market
- Spain Single Cell Sequencing Market
- China Single Cell Sequencing Market
- India Single Cell Sequencing Market
- South Korea Single Cell Sequencing Market
- Australia Single Cell Sequencing Market
- Brazil Single Cell Sequencing Market
- Mexico Single Cell Sequencing Market
- Rest Of Europe Single Cell Sequencing Market
- Rest Of Asia Pacific Single Cell Sequencing Market
- Rest Of Latin America Single Cell Sequencing Market
- Ksa Single Cell Sequencing Market
- Other GCC Countries Single Cell Sequencing Market
- UAE Single Cell Sequencing Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report
